Key result
Transfemoral angiography is linked to non-puncture site platelet deposition in ~44% of patients.
Why the study?
The incidence and distribution of thromboembolitic events following transfemoral angiography were not well characterized using indium-111 labeled platelets.
What is the incidence and location of platelet deposition in patients undergoing transfemoral angiography?
Observational (n=27)
What is the incidence and location of platelet deposition in patients undergoing transfemoral angiography?
Transfemoral angiography frequently causes subclinical platelet deposition along the catheter path and at the puncture site, highlighting the potential need for improved catheter materials or antithrombotic therapy.
Answers are grounded in this paper and cite their sources.
Subclinical platelet deposition may occur during angiography; hypothesis-generating for indium-111 imaging in thromboembolic risk assessment.
The incidence of thromboembolitic events in patients undergoing transfemoral angiography was examined using indium-111 labeled platelets. Twenty-seven patients received approximately 300 muCi of autologous labeled platelets at least 3 hours before angiography and were scanned with a gamma camera immediately before and after angiography. All patients were free of clinically obvious complications in the 1-2 day period after angiography. Our results showed evidence of platelet deposition at 21 sites other than the puncture site in 12 (44%) patients. Most platelet deposition (54%) occurred along the region between the puncture site and the aortic bifurcation; 24% occurred at sites not traversed by the catheter. At the puncture site itself, there was substantial platelet uptake in 44% of patients. This study indicates the need for further work in determining the most suitable catheter material and in assessing the efficacy of other measures such as anticoagulant or antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
O’Connor et al. (1986) conducted an observational in Patients undergoing transfemoral angiography (n=27). Transfemoral angiography was evaluated on Platelet deposition at sites other than the puncture site. Transfemoral angiography resulted in indium-111 labeled platelet deposition at sites other than the puncture site in 44% of patients.
Synapse has enriched 10 related papers. Consider them for comparative context: